: One of his notable studies focuses on patients who are ineligible for brachytherapy (internal radiation). He utilizes a "simultaneous integrated boost" technique to deliver higher doses of radiation more accurately using VMAT and Helical Tomotherapy.
Below is an article summarizing his recent contributions to cancer treatment research.
Sarpün’s recent studies address critical challenges in treating "locally advanced" cancers—cases where a tumor has spread beyond its original site but remains in the general area. His research provides vital data for clinical decision-making in several key areas: : One of his notable studies focuses on
As a recognized researcher with a verified ORCID profile , Sarpün’s contributions are part of a global, transparent record of scientific progress. His ongoing work continues to push the boundaries of how we use physics to fight one of humanity's most persistent health challenges. İsmail Hakkı SARPÜN (0000-0002-9788-699X) - ORCID
: Research in medical physics is rarely a solo endeavor. Sarpün frequently collaborates with a diverse team of specialists, including M. İ. Sekmen and T. Koca, ensuring that the findings are grounded in both theoretical physics and practical clinical application. Why This Matters Sekmen and T. Koca
Advancing Precision in Cancer Care: The Work of İsmail Hakkı Sarpün
: By analyzing "dosimetry"—the calculation and assessment of the radiation dose received by the human body—his work helps hospitals choose the most effective machinery and software for specific patient needs. including M. İ.
The tag is part of an ORCID iD (specifically 0000-0002-9788-699X ), a digital identifier for researchers. This particular ID belongs to İsmail Hakkı SARPÜN , a researcher in the field of Medical Physics and Radiotherapy .